Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5192222
Max Phase: Preclinical
Molecular Formula: C48H82N12O16
Molecular Weight: 1083.25
Associated Items:
ID: ALA5192222
Max Phase: Preclinical
Molecular Formula: C48H82N12O16
Molecular Weight: 1083.25
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)O
Standard InChI: InChI=1S/C48H82N12O16/c1-10-24(7)37(45(72)53-28(19-32(51)61)41(68)55-30(21-34(64)65)47(74)60-18-14-16-31(60)48(75)76)58-39(66)26(9)52-43(70)35(22(3)4)57-46(73)38(25(8)11-2)59-42(69)29(20-33(62)63)54-44(71)36(23(5)6)56-40(67)27(50)15-12-13-17-49/h22-31,35-38H,10-21,49-50H2,1-9H3,(H2,51,61)(H,52,70)(H,53,72)(H,54,71)(H,55,68)(H,56,67)(H,57,73)(H,58,66)(H,59,69)(H,62,63)(H,64,65)(H,75,76)/t24-,25-,26-,27-,28-,29-,30-,31-,35-,36-,37-,38-/m0/s1
Standard InChI Key: NQEJDXWZOONROE-FGUQEMMXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1083.25 | Molecular Weight (Monoisotopic): 1082.5972 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Yoshida J, Takayama K, Kawada M.. (2022) Short peptides derived from hGAPDH exhibit anti-cancer activity., 71 [PMID:35964520] [10.1016/j.bmc.2022.116953] |
Source(1):